Goldman Sachs’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,476,901
Closed -$58.7M 7622
2015
Q4
$58.7M Sell
2,476,901
-1,520,434
-38% -$35.4M 0.02% 1003
2015
Q3
$79.9M Buy
3,997,335
+164,405
+4% +$3.29M 0.03% 754
2015
Q2
$74.1M Buy
3,832,930
+174,871
+5% +$3.62M 0.02% 849
2015
Q1
$82.9M Buy
3,658,059
+26,329
+0.7% +$605K 0.03% 744
2014
Q4
$78.2M Sell
3,631,730
-532,585
-13% -$11.3M 0.02% 806
2014
Q3
$84.1M Buy
4,164,315
+91,110
+2% +$1.98M 0.03% 726
2014
Q2
$88.9M Buy
4,073,205
+30,928
+0.8% +$657K 0.03% 734
2014
Q1
$82.8M Sell
4,042,277
-1,210,553
-23% -$23.9M 0.03% 704
2013
Q4
$95.2M Buy
5,252,830
+259,622
+5% +$4.92M 0.03% 656
2013
Q3
$92.8M Buy
4,993,208
+1,060,528
+27% +$20.8M 0.03% 629
2013
Q2
$79.6M Buy
+3,932,680
New +$85.1M 0.03% 640

Other funds holding BMR

Goldman Sachs's BMR Position: Q1 2016 in Review

Goldman Sachs sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 2,476,901 shares — an estimated $58.7M sold.

Goldman Sachs first reported a position in BMR in Q2 2013 and held it in 11 quarters. The position peaked at $95.2M in Q4 2013. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

  • Goldman Sachs reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
  • Goldman Sachs sold 2,476,901 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $58.7M.
  • Goldman Sachs first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 11 quarters.
  • Goldman Sachs's BIOMED REALTY TRUST INC position peaked at $95.2M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.